83/100 A · Moderate risk
No major risk flags in public sources TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.

✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)

LABORATOIRES EXPANSCIENCE

Active 5710 2042 Active for 41 years

5710 · RC 331930081 · Active since 1985

A

Overview

LABORATOIRES EXPANSCIENCE is a 5710 registered , France, since 1985. The company operates in the 2042 sector. With reported revenue of 216.7M EUR in 2024. Its TraceComp score of 83 (A) indicates solid fundamentals and low apparent risk. With 41 years of operations, the company has an established track record in its market.

Company Information

Registration Number
331930081
Legal Form
5710
Registered
1985-01-01

Financial Profile

Latest filed accounts: FY 2024

Revenue (2024) 216,732,806 EUR
Net Income 5,954,747 EUR
Total Assets 172,407,343 EUR
Altman Z 1.94 grey

Multi-year financials & ratios

5 years of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Officers & Management

5 officers/directors on file — names, roles, appointment & resignation dates.

NameRoleStatus
CABINET P. CASTAGNET role 71 Current
+ 4 more in the full report

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Patent Portfolio

Active patent holder. 75 patents · 56 active · 75 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Corporate Group & Ownership

Parent entities from the GLEIF global ownership graph (LEI Level 2).

RelationshipParent entityCountry
Direct parent EXPANSCIENCE FR
Ultimate parent EXPANSCIENCE FR

Risk Signals

No adverse legal events have been recorded for this company.

  • Profitable: positive net income in FY 2024

Data Sources & Freshness

Data sourced from: bulk register.